262 related articles for article (PubMed ID: 28114674)
1. Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.
Berry K; Butt M; Kirby JS
JAMA Dermatol; 2017 May; 153(5):421-426. PubMed ID: 28114674
[TBL] [Abstract][Full Text] [Related]
2. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
[TBL] [Abstract][Full Text] [Related]
3. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
4. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
5. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
7. Variation in the Cost of Managing Actinic Keratosis.
Kirby JS; Gregory T; Liu G; Leslie DL; Miller JJ
JAMA Dermatol; 2017 Apr; 153(4):264-269. PubMed ID: 28249074
[TBL] [Abstract][Full Text] [Related]
8. The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
Cerio R
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022
[TBL] [Abstract][Full Text] [Related]
9. Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.
Noels EC; Lugtenberg M; van Egmond S; Droger SM; Buis PAJ; Nijsten T; Wakkee M
Br J Dermatol; 2019 Jul; 181(1):96-104. PubMed ID: 30801664
[TBL] [Abstract][Full Text] [Related]
10. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
11. Patients' perspectives on actinic keratosis.
Esmann S
Curr Probl Dermatol; 2015; 46():8-13. PubMed ID: 25561200
[TBL] [Abstract][Full Text] [Related]
12. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
13. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
14. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
15. [When and why treat actinic keratoses?].
Wulf HC
Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
[TBL] [Abstract][Full Text] [Related]
16. Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis.
Peris K; Neri L; Fargnoli MC; Pellacani G
G Ital Dermatol Venereol; 2014 Apr; 149(2):193-8. PubMed ID: 24819639
[TBL] [Abstract][Full Text] [Related]
17. Reexamination of field-directed therapy for actinic keratosis.
Rosen T
Cutis; 2012 Oct; 90(4):163-5. PubMed ID: 23259199
[No Abstract] [Full Text] [Related]
18. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life, Behaviour and Attitudes towards Actinic Keratosis in Spain: The PIQA Study.
Longo I; Serra-Guillén C
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):331-339. PubMed ID: 29477269
[TBL] [Abstract][Full Text] [Related]
20. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]